Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ZB131 |
Synonyms | |
Therapy Description |
ZB131 is a monoclonal antibody targeting cancer specific plectin (CSP), which potentially induces cell cycle arrest and inhibits migration and tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 3591). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ZB131 | ZB 131|ZB-131 | ZB131 is a monoclonal antibody targeting cancer specific plectin (CSP), which potentially induces cell cycle arrest and inhibits migration and tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 3591). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05074472 | Phase Ib/II | ZB131 | A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors | Completed | USA | 0 |